6505-01-329-6495 ( EULEXIN , NDC00085-0525-03 , NDC00085-0525-03 , NDC00185-1125-88 )

NSN Information
NSN FSC NIIN Item Name INC
6505-01-329-6495 6505 013296495 FLUTAMIDE CAPSULES,USP 6674
NSN Features
MRC Parameter Characteristics
CQLS CAPSULE CONTENT FORM ANY ACCEPTABLE
PKTY UNIT PACKAGE TYPE PACKAGE
AJCN PROTECTIVE STORAGE FEATURE ANTINEOPLASTIC DRUG
FEAT SPECIAL FEATURES 100 CAPSULES PER PACKAGE
CBBL FEATURES PROVIDED UNIT DOSE
CQCT PRIMARY CONTAINER TYPE STRIP
SUPP SUPPLEMENTARY FEATURES NOTE D: ANTINEOPLASTIC (CHEMOTHERAPY) DRUG
AKJC CAPSULE TYPE ANY ACCEPTABLE
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY FLUTAMIDE CAPSULES USP 125ML STRIPS 100S PG
CYLZ CAPSULE PRIMARY CONTAINER CONTENT QUANTITY 100.000
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 125.000 MILLIGRAMS FLUTAMIDE ACTIVE INGREDIENT
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
EULEXIN 1F095 A 1 5 4 KX
NDC00085-0525-03 53300 A 2 3 4 ZZ
NDC00085-0525-03 1F095 A 2 3 4 KX
NDC00185-1125-88 0WTU2 A 2 3 4 ZZ
Manufacturers
Part SKU Cage Manufacturer Type Status
EULEXIN 1F095 SCHERING-PLOUGH CORPORATION A A
NDC00085-0525-03 53300 SCHERING CORP A A
NDC00085-0525-03 1F095 SCHERING-PLOUGH CORPORATION A A
NDC00185-1125-88 0WTU2 EON LABS INC. A A
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
A X A 1 11/20/1 P 3004909190 6674
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
DS I R REFER TO EDI ITEM
DA C2201X- A V DISCONTINUED W/O REPLACEMENT
DS I K U/I CONTAINS 3 EA
DN 9B----- N K U/I CONTAINS 3 EA
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A A P X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
DA SMS Y 1 PG M U C2201X- A
DS SMS L 1 PG M U D
DN SMS L 1 PG M U 9B----- N
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
C 2 2 01 X
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC